Saxon, Switzerland

Patrick Garrouste

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovations of Patrick Garrouste

Introduction

Patrick Garrouste is a notable inventor based in Saxon, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of slow-release drug formulations. With a total of two patents to his name, Garrouste's work focuses on innovative solutions for medical applications.

Latest Patents

Garrouste's latest patents include a "Slow release pharmaceutical composition made of microgranules." This invention involves a pharmaceutical composition designed for the slow release of an active substance over a period of at least six months after injection. The composition comprises microparticles made from a copolymer of the PLGA type, which incorporates a water-insoluble peptide salt. The copolymer consists of at least 75% lactic acid and has a specific inherent viscosity. The microparticles are characterized by a defined size distribution, ensuring effective delivery of the active substance.

Another significant patent is related to "Cycloundecadepsipeptide compounds and use of said compounds as a medicament." This invention focuses on new cycloundecadepsipeptide compounds and their application as antiviral agents, particularly for preventing or treating Hepatitis C infections and related disorders.

Career Highlights

Throughout his career, Patrick Garrouste has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Debiopharm Research & Manufacturing SA and Debio Recherche Pharmaceutique SA. His work in these organizations has contributed to advancements in drug development and delivery systems.

Collaborations

Garrouste has collaborated with esteemed professionals in the field, including Bertrand Ducrey and Catherine Curdy. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Patrick Garrouste's contributions to pharmaceutical innovations highlight his expertise and commitment to advancing medical science. His patents reflect a deep understanding of drug formulation and delivery, making a significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…